Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer
- 30 September 2009
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 45 (13) , 2284-2292
- https://doi.org/10.1016/j.ejca.2009.04.029
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapyCancer, 2009
- Axillary Staging Prior to Neoadjuvant Chemotherapy for Breast Cancer: Predictors of RecurrenceAnnals of Surgical Oncology, 2008
- Is There a Role for Positron Emission Tomography in Breast Cancer Staging?Journal of Clinical Oncology, 2008
- Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient OutcomeJournal of Clinical Oncology, 2007
- Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancerBritish Journal of Surgery, 2006
- Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancerBritish Journal of Surgery, 2006
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2005
- Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph NodesJournal of Clinical Oncology, 2002
- Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2000